Clinical Trial: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of TESP-0401 in Healthy Participants

U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07658638) titled 'A Study to Investigate the Safety, Tolerability and Pharmacokinetics of TESP-0401 in Healthy Participants' on June 02.

Brief Summary: The goal of this intervention study is to evaluate the safety and tolerability of TESP-0401, and to understand how the body processes TESP-0401, in healthy participants after single and multiple doses. The study aims to answer the following questions: 1. What are the safety, tolerability, and pharmacokinetic characteristics of a single dose of TESP-0401 in healthy participants? 2. What are the safety, tolerability, and pharmacokinetic characteristics of multiple doses of TESP-0401 in healthy participa...